Regis Jean-Pierre Simard
Fortune : 527 168 $ au 31/05/2026
Fortune : 527 168 $ au 31/05/2026
Regis Jean-Pierre Simard is currently the Director at ViiV Healthcare Ltd. and the President-Global Supply Chain at GSK Plc.
Previously, he served as the Non-Executive Director at GlaxoSmithKline Pharmaceuticals Ltd. from 2015 to 2017.
He also held a position as Director at Glaxo Operations UK Ltd.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GSK PLC 0% | 09/06/2026 | 20 786 ( 0% ) | 527 168 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/09/2018 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur/Membre du Conseil | 31/03/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 11/02/2017 |
Glaxo Operations UK Ltd.
Glaxo Operations UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
GlaxoSmithKline Pharmaceuticals Ltd.
GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the business of manufacturing, distributing and trading in pharmaceuticals | Health Technology |
Glaxo Operations UK Ltd.
Glaxo Operations UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national